google.com, pub-pub-9265584400550148, DIRECT, f08c47fec0942fa0
Skip to content Skip to footer

Discovery & Development Summit Asia 2025

Discovery & Development Summit Asia 2025 is Global Engage’s inaugural platform that brings together the Drug Discovery & Development, Nucleic Acid Therapeutics and Precision Medicine congresses. This summit allows the exploration of the full spectrum of therapeutic innovation, from early-stage discovery to clinical translation and commercialization. Attendees will gain insights into assay development, screening technologies,…

Read more

ThoughtSpot_Carla Adams3

The Future of Personalized Medicine – How Pharma is Tailoring Treatments to Individuals

Personalized medicine is rapidly becoming a cornerstone of modern healthcare, promising to redefine how treatments are tailored to individual patients. Unlike traditional approaches, which often rely on a one-size-fits-all model, personalized medicine uses detailed information about a person’s genetic makeup, lifestyle, and environment to create more effective and precise treatments. This approach is gaining traction…

Read more

New Drug Designations - September 2023

New Drug Designations – September 2023

Shots:  PharmaShots' designation report provides a concise overview of several drugs and their designations by the US FDA, the EU, and China. This month’s report includes 10 biological drugs, 15 small molecules, 5 cell and gene therapies, 4 devices, 1 vaccine and 1 microbiota  MicuRx’ Contezolid and Contezolid acefosamil, focused on the treatment of Diabetic…

Read more

ThoughtSpot_Saurabh Chaubey

Competitive Intelligence: A Substantial Advantage for the Pharmaceutical Sector

“The supreme art of war is to subdue the enemy without fighting” – Sun Zhu, Competitive Intelligence benefits your organization gather and analyzing information related to your competitor’s business models. This deep analysis helps your organization reduce the strategic risks and increase revenue opportunities by attaining deep insights into how the market has changed and…

Read more